Application Nr Approved Date Route Status External Links
ANDA078154 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Levetiracetam Tablets Usp Are Indicated For The Treatment Of Partial-Onset Seizures In Patients 1 Month Of Age And Older (1.1) Levetiracetam Tablets Usp Are Indicated For Adjunctive Therapy For Treatment Of: Partial Onset Seizures In Patients One Month Of Age And Older With Epilepsy ( 1.1 ) Myoclonic Seizures In Patients 12 Years Of Age And Older With Juvenile Myoclonic Epilepsy ( 1.2 ) Primary Generalized Tonic-Clonic Seizures In Patients 6 Years Of Age And Older With Idiopathic Generalized Epilepsy ( 1.3 ) 1.1 Partial Onset Seizures Levetiracetam Tablets Usp Are Indicated For Treatment Of Partial-Onset Seizures In Patients 1 Month Of Age And Older. 1.2 Myoclonic Seizures In Patients With Juvenile Myoclonic Epilepsy Levetiracetam Tablets Usp Are Indicated As Adjunctive Therapy For The Treatment Of Myoclonic Seizures In Patients 12 Years Of Age And Older With Juvenile Myoclonic Epilepsy. 1.3 Primary Generalized Tonic-Clonic Seizures Levetiracetam Tablets Usp Are Indicated As Adjunctive Therapy For The Treatment Of Primary Generalized Tonic-Clonic Seizures In Patients 6 Years Of Age And Older With Idiopathic Generalized Epilepsy.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Levetiracetam LEVETIRACETAM ZINC1547851

Comments